Posts

Slate Uses Fulcrum to Join Nasdaq With $245M Financing for Migraine Trials

on

AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure (August 17, 2026)

on

Merck KGaA Lays Off 20 Staffers in Latest Blow to US Research Team

on

How AI-Enabled SaMD Are Reshaping Regulatory Routes and Medicine

on

Redx tries again at reverse merger with Skye, as alternative route gains steam

on

Cytokinetics Brings Patent Suit Against Bristol Myers, Escalating Rivalry

on

Biogen's monoclonal antibody felzartamab wins first global approval in China

on

AstraZeneca Cans Late-Stage Bispecific Trial After Lung Cancer Setback

on

Aizen Therapeutics secures oral peptide deal with unnamed San Diego biopharma

on

Capricor surges on plan to amend DMD filing after adcom setback

on

Trump Signs Executive Order to Overhaul Pediatric Vaccine Recommendations

on

Tavneos (Avacopan) Markets Withdrawn in EU Over Clinical Trial Data Integrity Breaches and Serious Hepatic Risks

on

Zenbexus: BMS earns first FDA approval for CELMoD class in multiple myeloma

on